Welcome to LookChem.com Sign In|Join Free

CAS

  • or

4097-22-7

Post Buying Request

4097-22-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4097-22-7 Usage

Description

Dideoxyadenosine, also known as 2',3'-dideoxyadenosine (ddA), is a purine 2',3'-dideoxyribonucleoside in which the nucleobase component is specified as adenine. It is an off-white to beige powder with unique chemical properties that make it a valuable compound in various applications.

Uses

Used in Pharmaceutical Industry:
Dideoxyadenosine is used as a potent anti-HIV agent for its ability to inhibit the replication of the human immunodeficiency virus (HIV). It plays a crucial role in the treatment and management of HIV/AIDS by helping to control the viral load and prevent the progression of the disease.
Used in Research and Development:
Dideoxyadenosine is used as a specific adenylyl cyclase inhibitor in biological process and pathway studies involving adenylyl cyclase activity and cAMP pool modulation. This application is essential for understanding the role of adenylyl cyclase in various cellular processes and its potential as a therapeutic target for various diseases.
Used in Diagnostics:
As a potent labeled anti-HIV agent, Dideoxyadenosine can be utilized in the development of diagnostic tools and tests for the detection and monitoring of HIV infection. This application aids in the early identification of the virus and the implementation of appropriate treatment strategies.

Air & Water Reactions

Water soluble.

Reactivity Profile

Dideoxyadenosine may be sensitive to prolonged exposure to light.

Health Hazard

SYMPTOMS: Symptoms of exposure to a related compound include cutaneous eruptions, fever, mouth sores, thrombocytopenia, neutropenia, reversible peripheral neuropathy, gastrointestinal distress, headache, nausea and vomiting.

Fire Hazard

Flash point data for Dideoxyadenosine are not available; however, Dideoxyadenosine is probably combustible.

Check Digit Verification of cas no

The CAS Registry Mumber 4097-22-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,0,9 and 7 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 4097-22:
(6*4)+(5*0)+(4*9)+(3*7)+(2*2)+(1*2)=87
87 % 10 = 7
So 4097-22-7 is a valid CAS Registry Number.

4097-22-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (D3065)  2',3'-Dideoxyadenosine  >98.0%(HPLC)(T)

  • 4097-22-7

  • 100mg

  • 3,650.00CNY

  • Detail
  • Sigma-Aldrich

  • (Y0000442)  Didanosine impurity G  European Pharmacopoeia (EP) Reference Standard

  • 4097-22-7

  • Y0000442

  • 1,880.19CNY

  • Detail
  • USP

  • (1191237)  Didanosine Related Compound B  United States Pharmacopeia (USP) Reference Standard

  • 4097-22-7

  • 1191237-25MG

  • 14,578.20CNY

  • Detail

4097-22-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 2',3'-Dideoxyadenosine

1.2 Other means of identification

Product number -
Other names ((2S,5R)-5-(6-Amino-9H-purin-9-yl)tetrahydrofuran-2-yl)methanol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4097-22-7 SDS

4097-22-7Relevant articles and documents

A MILD CONVERSION OF VICINAL DIOLS TO ALKENES. EFFICIENT TRANSFORMATION OF RIBONUCLEOSIDES INTO 2'-ENE AND 2',3'-DIDEOXYNUCLEOSIDES

Robins, Morris J.,Hansske, Fritz,Low, Nicholas H.,Park, Ja In

, p. 367 - 370 (1984)

α-Acetoxyisobutyryl bromide in "moist" acetonitrile converted adenosine to trans-3'(2')-bromo-2'(3')-acetates with 3percent glycosyl cleavage.This mixture was acetylated, treated with Zn/Cu/DMF, and deacylated to give 81percent of the 2'-alkene.

A stent green synthesis method (by machine translation)

-

Paragraph 0026; 0029; 0032; 0033; 0035; 0036; 0038, (2018/10/11)

The invention discloses a stent green synthesis method. The invention to a wide variety of sources adenosine as the starting material, passes through the cyclization, open-loop, catalytic hydrogenation - alkaline hydrolysis, adopts the steps are less, the obtained few by-products, and improves the yield, and reduces the production cost. (by machine translation)

An effective and convenient synthesis of cordycepin from adenosine

Huang, Shen,Liu, Hui,Sun, Yanhua,Chen, Jian,Li, Xiufang,Xu, Jiangfeng,Hu, Yuwei,Li, Yuqing,Deng, Zhiwei,Zhong, Shian

, p. 149 - 160 (2018/01/17)

Cordycepin is a purine nucleoside analog with potent and diverse biological activities. Herein, we designed two methods to synthesize cordycepin. One method mainly converted the 3′-OH group into an iodide group and further dehalogenation to yield the final product. Although this method presented a short synthetic procedure, the synthesis had a low overall yield, resulting in only 13.5% overall yield. To improve the overall yield of cordycepin, another synthetic route was studied, which consisted of four individual steps: (1) 5′-OH protection (2) esterification (3) -O-tosyl (-OTs) group removal (4) deprotection. The key step in the synthetic method involved the conversion of 5′-O-triphenylmethyladenosine to 3′-O-tosyl-5′-O-triphenylmethyladenosine, using LiAlH4 as reducing agent. The main advantages of this route were an acceptable total product yield and the commercial availability of all starting materials. The optimal reaction conditions for each step of the route were identified. The overall yield of cordycepin obtained from adenosine as the starting material was 36%.

Continuous flow photochemistry for the rapid and selective synthesis of 2′-deoxy and 2′,3′-dideoxynucleosides

Shen, Bo,Jamison, Timothy F.

, p. 157 - 164 (2013/04/10)

A new photochemical flow reactor has been developed for the photo-induced electron-transfer deoxygenation reaction to produce 2′-deoxy and 2′,3′-dideoxynucleosides. The continuous flow format significantly improved both the efficiency and selectivity of the reaction, with the streamlined multi-step sequence directly furnishing the highly desired unprotected deoxynucleosides.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4097-22-7